Plasma cytokines as predictors of coronary heart disease

Research Communications in Molecular Pathology and Pharmacology

Volumn 112, Issue 1-4, 2002, Pages 5-15

  Okopien B ^a   Haberka, M ^a   Cwalina, L ^a   Kowalski, J ^a   Belowski, D ^a   Madej, A ^a   Zielinski M ^a   Krysiak, R ^a   Labuzek K ^a   Kalina, Z ^a   Herman, Z S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute coronary syndrome (ACS); Coronary heart disease (CHD); Correlation with cytokines; Cytokines; Defective fibrinolysis; ELISA; Inflammation; Interleukin 10 (IL 10); Metalloproteinases (MMP); Monocyte chemotactic protein (MCP); Patients; Plasma cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; MONOCYTE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THROMBOSIS; VASCULAR DISEASE;

ADULT; ANGINA PECTORIS; CHEMOKINE CCL2; CORONARY DISEASE; CYTOKINES; EXERCISE TEST; FEMALE; HUMANS; INTERLEUKIN-10; LIPIDS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS;

EID: 12144287596     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature ;394:894-897
2. Cesari M, Rossi G.P. (1999) Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy. Arteriosclerosis, Thrombosis and Vasc. Biol.; 19:1378-1386
3. Davies (1996) Stability and Instability: two faces of coronary atherosclerosis. Circulation ;94:2013-2020
4. Feldman L.J., Aguirre L, Ziol M, Bridou J.P., Nevo N, Michel J.B., Steg G (2000) Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation; 101:908-916
5. Frangogiannis N.G., Mendoza L.H., Lindsey M.L., Ballantyne Ch.M., Michael L.H., Smith W.C., Entman M.L. (2000) IL-10 Is induced in the reperfused myocardium and may modulate the reaction to injury. J. Immunol.; 165:2798-2808
6. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ (1998) Absence of monocyte chemoattractant peptide 1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell; 2:275-281
7. Held C, Hjemdahl P, Rehnqvist N, Wallen N.H., Bjorkander I, Eriksson S, Forslund L, Wiman B (1997) Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol: results from the angina prognosis study in Stockholm. Circulation; 95:2380-2386
8. Hojo Y, Ikeda U, Takahashi M, Shimada K (2002) Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis; 161:403-8
9. Kohler H.P., Grant P.J. (2000) Mechanisms of disease: Plasminogen activator inhibitor type 1 and coronary artery disease. N Engl J Med; 342:1792-1801
10. Koyanagi M, Egashira K, Kitamoto S, Ni W, Shimokawa H, Takeya M, Yoshimura T, Takeshita A (2000) Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of Nitric Oxide synthesis. Circulation ;102:2243-2248
11. Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation; 91:2844-2850
12. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau M.F., Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of Interleukin-10 in atherosclerosis. Circulation Research ;85:e17-24
13. Mallat Z, Heymes Ch, Ohan J, Faggin E, Lesche G, Tedgui A (1999) Expression of Interleukin-10 in advanced human atherosclerosis plaques. Arteriosclerosis, Thrombosis and Vascular Biology; 19:611-616
14. Mazzone A, De Servi S, Mazzucchelli I, Bossi I, Ottini E, Vezzoli M, Meloni F, Lotzinker M, Mariani G (2001) Increased concentrations of inflammatory mediators in Unstable Angina: correlation with serum troponin T. Heart; 85:571-575
15. Moreno P.R., Bernardi V.H., Lopez-Cuellar J, Murcia A.M., Palacios I.F., Gold H.K., Mehran R, Sharma S.K., Nemerson Y, Fuster V, Fallon J.T. (1996) Macrophages, smooth muscle cells and tissue factor in unstable angina. Circulation; 94:3090-3097
16. Negri M, Sheiban I, Arigliano PL, Tonni S, Montresor G, Carlini S, Manzato F (1993) Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and Plasminogen Activator Inhibitor-1. American Journal of Cardiology; 72:397-401
17. Okada K, Fujita T, Minamoto K, Liao H, Naka Y, Pinsky D.J. (2000) Potentation of endogenous fibrinolysis and rescue from lung ischemia/ reperfusion injury in Interleukin (IL)-10 reconstituted IL-10 Null mice. J Biol Chem; 275:21468-21476
18. Oseroff A, Krishnamurti C, Hasset A, Tang D, Alving B (1989) Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J. Lab. Clin. Med; 113:88-93
19. Price D.T., Loscalzo J (1999) Cellular adhesion molecules and atherogenesis. Am J Med ;107:85-97
20. Rollins BJ (1996) Monocyte chemoattractant protein-1:a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today; 2:198-204
21. Ross R (1999) Atherosclerosis - An Inflammatory Disease. N Eng J Med; 340:115-126
22. Salomaa V, Stinson V, Kark J.D., Folsom A.R., Davis C.E., Wu K.K. (1995) Association of fibrinolytic parameters with early atherosclerosis. Circulation; 91:284-290
23. Schmidt A.M., Stern D.M. Chemokines on the rise: MCP-1 and restenosis Arteriosclerosis, Thromb. Vasc. Biol.; 21:297-299
24. Smith D.A., Irving S.D., Sheldon J, Cole D, Kaski J.C (2001) Serum levels of the antinflammatory cytokine Interleukin-10 are decreased in patients with unstable angina. Circulation; 104:746-749
25. Sobel B.E. (1999) Increased Plasminogen Activator Inhibitor-1 and vasculopathy: A reconcilable paradox. Circulation; 99:2496-2498
26. Tedgui A, Mallat Z (2001) Anti-inflammatory mechanisms in the vascular wall. Circulation Research; 88:877-887
27. Thompson S.G., Kienast J, Pyke S, Haverkate F, van de Loo J, the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med; 332:635-641
28. Veltrop M, Langermans J, Thompson J, Bancsi M (2001) Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis. Infection and Immunity; 69:3197-3202
29. Yang Z, Zingarelli B, Szabó C (2000) Crucial role of endogenous Interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation; 101:1019-1026